← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Hikma Pharmaceuticals
-4.0%
Pharma / Pharmaceuticals and Generic Medicines
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebBalance Sheet
Pay attention and research significant changes from year to year values. [ ! ]
| Fixed Column | Cash And Cash Equivalents | Short Term Investments | Cash And Short Term Investments | Net Receivables | Inventory | Other Current Assets | Total Current Assets | Property Plant Equipment Net | Goodwill | Intangible Assets | Goodwill And Intangible Assets | Long Term Investments | Tax Assets | Other Non Current Assets | Total Non Current Assets | Other Assets | Total Assets | Account Payables | Short Term Debt | Tax Payables | Deferred Revenue | Other Current Liabilities | Total Current Liabilities | Long Term Debt | Deferred Revenue Non Current | Deferred Tax Liabilities Non Current | Other Non Current Liabilities | Total Non Current Liabilities | Other Liabilities | Capital Lease Obligations | Total Liabilities | Preferred Stock | Common Stock | Retained Earnings | Accumulated Other Comprehensive Income Loss | Other Total Stockholders Equity | Total Stockholders Equity | Total Equity | Total Liabilities And Stockholders Equity | Minority Interest | Total Liabilities And Total Equity | Total Investments | Total Debt | Net Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12 | 205.0 | 24.0 | 229.0 | 789.0 | 891.0 | 191.0 | 2100.0 | 1141.0 | 388.0 | 712.0 | 1100.0 | 65.0 | 0.0 | 274.0 | 2580.0 | 0.0 | 4680.0 | 309.0 | 161.0 | 74.0 | 0.0 | 795.0 | 1339.0 | 1030.0 | 0.0 | 25.0 | 77.0 | 1132.0 | 0.0 | 66.0 | 2471.0 | 0.0 | 40.0 | 2158.0 | -281.6 | 281.6 | 2198.0 | 2209.0 | 4680.0 | 11.0 | 4680.0 | 83.0 | 1191.0 | 986.0 |
| 2022-12 | 270.0 | 22.0 | 270.0 | 777.0 | 776.0 | 154.0 | 1999.0 | 1081.0 | 389.0 | 735.0 | 1124.0 | 53.0 | 192.0 | 22.0 | 2472.0 | 0.0 | 4471.0 | 291.0 | 148.0 | 73.0 | 290.0 | 275.0 | 1077.0 | 1135.0 | 0.0 | 19.0 | 111.0 | 1246.0 | 0.0 | 70.0 | 2323.0 | 280.5 | 40.0 | 2092.0 | -280.5 | 282.0 | 2135.0 | 2148.0 | 4471.0 | 13.0 | 4471.0 | 75.0 | 1283.0 | 1013.0 |
| 2021-12 | 426.0 | 24.0 | 426.0 | 781.0 | 695.0 | 168.0 | 2094.0 | 1146.0 | 285.0 | 607.0 | 892.0 | 33.0 | 183.0 | 24.0 | 2278.0 | 0.0 | 4372.0 | 262.0 | 121.0 | 57.0 | 294.0 | 282.0 | 1016.0 | 725.0 | 0.0 | 24.0 | 164.0 | 889.0 | 0.0 | 83.0 | 1905.0 | 59.88 | 42.0 | 2189.0 | -59.88 | 282.0 | 2453.0 | 2467.0 | 4372.0 | 14.0 | 4372.0 | 57.0 | 846.0 | 420.0 |
| 2020-12 | 323.0 | 24.0 | 323.0 | 662.0 | 757.0 | 156.0 | 1922.0 | 1068.0 | 289.0 | 587.0 | 876.0 | 24.0 | 221.0 | 24.0 | 2213.0 | 0.0 | 4135.0 | 279.0 | 168.0 | 72.0 | 100.0 | 509.0 | 1028.0 | 764.0 | 0.0 | 31.0 | 195.0 | 959.0 | 0.0 | 82.0 | 1987.0 | 79.99 | 41.0 | 1892.0 | -79.99 | 282.0 | 2135.0 | 2148.0 | 4135.0 | 13.0 | 4135.0 | 48.0 | 932.0 | 609.0 |
Wait! There's more — sign up for free or log in